Published on in Vol 5, No 5 (2017): May

Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability

Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability

Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability

Journals

  1. Dramburg S, Marchante Fernández M, Potapova E, Matricardi P. The Potential of Clinical Decision Support Systems for Prevention, Diagnosis, and Monitoring of Allergic Diseases. Frontiers in Immunology 2020;11 View
  2. Pappa D, Stergioulas L. Harnessing social media data for pharmacovigilance: a review of current state of the art, challenges and future directions. International Journal of Data Science and Analytics 2019;8(2):113 View
  3. TİFTİK N, DUMAN İ, ÜN İ. Bir Üniversite Hastanesinde Görev Yapan Hemşirelerin Farmakovijilans Hakkında Bilgi, Tutum ve Uygulamalarının Değerlendirmesi. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi 2019;9(3):285 View
  4. Doarn C, Vonder Meulen M, Pallerla H, Acquavita S, Regan S, Elder N, Tubb M. Challenges in the Development of e-Quit worRx: An iPad App for Smoking Cessation Counseling and Shared Decision Making in Primary Care. JMIR Formative Research 2019;3(1):e11300 View
  5. Ramsey A, Sheikh A. Innovations in Health Care Delivery: Drug Allergy. The Journal of Allergy and Clinical Immunology: In Practice 2019;7(7):2143 View
  6. Azad-Khaneghah P, Neubauer N, Miguel Cruz A, Liu L. Mobile health app usability and quality rating scales: a systematic review. Disability and Rehabilitation: Assistive Technology 2021;16(7):712 View
  7. Inomata T, Sung J, Nakamura M, Fujisawa K, Muto K, Ebihara N, Iwagami M, Fujio K, Okumura Y, Okano M, Murakami A. New medical big data for P4 medicine on allergic conjunctivitis. Allergology International 2020;69(4):510 View
  8. Pereira A, Jácome C, Almeida R, Fonseca J. How the Smartphone Is Changing Allergy Diagnostics. Current Allergy and Asthma Reports 2018;18(12) View
  9. Ithnin M, Mohamad nor N, Juliana N, Mohd Effendy N, Sahar M, Abang Abdullah K, Mohd Aris M, Mohd Rani M. Knowledge, attitudes and practices on risk factors of non-communicable diseases (NCDs): a cross-sectional survey among urban and rural adults in Negeri Sembilan, Malaysia. International Journal of Health Promotion and Education 2021;59(4):236 View
  10. KARATAŞ Y, KHAN Z, GÖREN ÖZAGİL E, ABUSSUUTOĞLU A, PELİT A, KOÇAK E. Knowledge, attitude and practices about pharmacovigilance and adverse drug reactions among dental research assistants in a Turkish hospital: a cross-sectional study. Journal of Health Sciences and Medicine 2020;3(4):367 View
  11. da Costa Lima E, de Barros Fernandes T, Freitas A, de Lima Sias J, Land M, Aires M, Bracken L, Peak M. Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children. BMC Medical Research Methodology 2021;21(1) View
  12. Balan S. Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review. International Journal of Pharmacy Practice 2021;29(4):308 View
  13. KC B, Alrasheedy A, Goh B, Blebil A, Bangash N, Mohamed Ibrahim M, Rehman I. The Types and Pattern of Use of Mobile Health Applications Among the General Population: A Cross-Sectional Study from Selangor, Malaysia. Patient Preference and Adherence 2021;Volume 15:1755 View
  14. Abbasi F, Khajouei R, Ahmadinejad M, Razban F, Jahani Y. Need assessment and development of a mobile-based medication dosage calculation application for ICU nurses. Health and Technology 2023;13(1):111 View
  15. Satwika M, Sushma D, Jaiswal V, Asha S, Pal T. The Role of Advanced Technologies Supplemented with Traditional Methods in Pharmacovigilance Sciences. Recent Patents on Biotechnology 2021;15(1):34 View
  16. Menang O, Kuemmerle A, Maigetter K, Burri C. Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review. BMJ Open 2023;13(9):e071079 View
  17. Putri R, Ikawati Z, Rahmawati F, Yasin N. An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy. Current Drug Safety 2024;19(3):317 View
  18. Khalil A, Gaol F, Sabarguna B, Prabowo H. Navigating personalized medication: unveiling user needs to forge a cutting-edge platform for proactive prevention and monitoring of adverse drug reactions. Requirements Engineering 2024 View

Books/Policy Documents

  1. Jones J, Bégaud B, Kingery E. Pharmacoepidemiology. View